March 12, 2025 - 18:55

In a significant move aimed at revitalizing its operations, Intel has appointed Lip-Bu Tan as its new Chief Executive Officer. This decision comes as the company embarks on a comprehensive turnaround strategy to enhance its competitive edge in the semiconductor industry. Tan, who has an extensive background in technology and leadership, is expected to bring fresh perspectives and innovative ideas to the company.
Following the announcement, Intel's stock experienced a remarkable surge, jumping by 11%. Investors are optimistic that Tan's leadership will steer the company towards greater profitability and market relevance, especially as the semiconductor landscape continues to evolve.
Additionally, reports indicate that Taiwan Semiconductor Manufacturing Company (TSMC) is looking to expand its manufacturing capabilities, further intensifying competition in the sector. As Intel navigates these challenges, Tan's appointment is seen as a pivotal step in positioning the company for future success. Stakeholders are hopeful that under his guidance, Intel will regain its status as a leader in semiconductor technology.
March 16, 2026 - 09:23
Reason RBA set to 'punish' Aussies as businesses warn of 'Covid 2.0' price spiralA stark warning from Australian businesses suggests the nation could be facing a new wave of inflationary pressure, reminiscent of the supply shocks seen during the pandemic. This looming threat is...
March 15, 2026 - 20:51
Did Warren Buffett Know Something Wall Street Doesn't? The Former Berkshire Hathaway CEO Left a $373 Billion Warning for the Stock Market.In his final years at the helm of Berkshire Hathaway, Warren Buffett executed a strategy that stood in stark contrast to the exuberance on Wall Street. While markets celebrated record highs, the...
March 15, 2026 - 09:07
5 Things Every UPS Investor Needs to KnowInvestors in United Parcel Service are navigating a complex environment as the company confronts new pressures on its strategic 2026 financial targets. A significant factor introducing uncertainty...
March 14, 2026 - 21:48
Caribou Biosciences Teases vispa-cel Phase 3 LBCL Plan, Eyes Financing at Leerink ConferenceAt the Leerink Global Healthcare Conference, executives from Caribou Biosciences detailed a strategic roadmap for the coming year, centering on the advancement of their primary investigational...